MedPath

Randomized control study comparing various modalities of thromboprophylaxis used after total knee and hip arthroplasty

Phase 4
Completed
Conditions
Health Condition 1: null- patients undergoing knee and hip arthoplasty
Registration Number
CTRI/2016/03/006736
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Indian patients undergoing hip and knee arthroplasty

Exclusion Criteria

patients aged <18 or > 90 years, patients with coagulation or bleeding disorders, hypersensitivity to aspirin or low molecular weight heparin, Heparin induced thrombocytopenia, history of thromboembolic disease/ chronic venous insufficiency, ocular or neurosurgical procedure during last 3 month, active peptic ulcer disease, severe renal insufficiency, systolic hypertension >200 mm Hg, pulmonary tuberculosis, a solid malignancy tumor, active Liver disease, peripheral vascular disease , and who refused to give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Deep vein thrombosis after arthroplastyTimepoint: within 3 months of surgery
Secondary Outcome Measures
NameTimeMethod
PETimepoint: 3 MONTHS
© Copyright 2025. All Rights Reserved by MedPath